Literature DB >> 309030

Aorta--coronary artery revascularization with an expanded polytetrafluoroethylene vascular graft. A preliminary report.

T Yokoyama, M A Gharavi, Y C Lee, W A Edmiston, J H Kay.   

Abstract

Patients requiring coronary artery surgery may have had bilateral saphenous vein stripping, and the arm veins may not be adequate for use for coronary artery grafting. The internal mammary artery may not be long enough for use for the circumflex or right coronary artery anastomoses. A suitable substitute would be most welcome for these patients or for those with marked varicosities of the saphenous vein. Five patients received expanded polytetrafluoroethylene (PTFE) grafts (Gore-Tex vascular grafts) for coronary artery revascularization because veins of adequate size or length were not available at the time of operation. These five patients are alive 9 to 14 months after graft insertion. Four of the five grafts were patent at the time of restudy 3 to 6 months postoperatively. More follow-up studies for far longer periods of time will be necessary before Gore-Tex vascular grafts can be recommended as the ideal material for coronary artery bypass surgery.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 309030

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

Review 1.  Advances in the development of grafts for bypass of small-caliber arteries.

Authors:  L R Sauvage
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

Review 2.  Electrospun silk biomaterial scaffolds for regenerative medicine.

Authors:  Xiaohui Zhang; Michaela R Reagan; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2009-07-28       Impact factor: 15.470

3.  Antiplatelet therapy reduces aortic intimal hyperplasia distal to small diameter vascular prostheses (PTFE) in nonhuman primates.

Authors:  P O Hagen; Z G Wang; E M Mikat; D B Hackel
Journal:  Ann Surg       Date:  1982-03       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.